{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:22:03Z","timestamp":1761578523255},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/s11920-001-0022-1","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T17:03:13Z","timestamp":1180717393000},"page":"295-301","source":"Crossref","is-referenced-by-count":1,"title":["Panic disorder"],"prefix":"10.1007","volume":"3","author":[{"given":"Mark Hyman","family":"Rapaport","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristin","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/ajp.151.3.413","volume":"151","author":"WW Eaton","year":"1994","unstructured":"Eaton WW, Kessler RC, Wittchen HU, Magee WJ: Panic and panic disorder in the United States. Am J Psychiatry 1994, 151:413\u2013420.","journal-title":"Am J Psychiatry"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archpsyc.1984.01790210041006","volume":"41","author":"JK Myers","year":"1984","unstructured":"Myers JK, Weissman MM, Tischler GL, et al.: Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 1984, 41:959\u2013967.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR4","first-page":"11","volume":"47","author":"MM Weissman","year":"1986","unstructured":"Weissman MM, Merikangas KR: The epidemiology of anxiety and panic disorders: an update. J Clin Psychiatry 1986, 47(suppl):11\u201317.","journal-title":"J Clin Psychiatry"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02193476","volume":"5","author":"D Klein","year":"1964","unstructured":"Klein D: Delineation of two-drug responsive anxiety syndromes. Psycopharmacologia 1964, 5:397\u2013408.","journal-title":"Psycopharmacologia"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1176\/ajp.119.5.432","volume":"119","author":"D Klein","year":"1962","unstructured":"Klein D, Fink M: Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962, 119:432\u2013438.","journal-title":"Am J Psychiatry"},{"key":"22_CR7","first-page":"12","volume":"51","author":"MH Pollack","year":"1990","unstructured":"Pollack MH, Otto MW, Rosenbaum JF, et al.: Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry 1990, 51(suppl):12\u201316.","journal-title":"J Clin Psychiatry"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archpsyc.55.11.1010","volume":"55","author":"MH Pollack","year":"1998","unstructured":"Pollack MH, Otto MW, Worthington JJ, et al.: Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry 1998, 55:1010\u20131016.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"22_CR9","first-page":"51","volume":"58","author":"MH Rapaport","year":"1997","unstructured":"Rapaport MH, Cantor JJ: Panic disorder in a managed care environment. J Clin Psychiatry 1997, 58(suppl)2:51\u201355.","journal-title":"J Clin Psychiatry"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1176\/appi.ajp.157.8.1204","volume":"157","author":"DF Klein","year":"2000","unstructured":"Klein DF: Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 2000, 157:1204\u20131211.","journal-title":"Am J Psychiatry"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","volume":"283","author":"DH Barlow","year":"2000","unstructured":"Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitivebehavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 2000, 283:2529\u20132536. A good article.","journal-title":"JAMA"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archpsyc.1994.03950050006001","volume":"5","author":"MK Shear","year":"1994","unstructured":"Shear MK, Maser JD: Standardized assessment for panic disorder research. A conference report. Arch Gen Psychiatry 1994, 5:346\u2013354.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/bjp.173.1.54","volume":"173","author":"PD Londborg","year":"1998","unstructured":"Londborg PD, Wolkow R, Smith WT, et al.: Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation. Br J Psychiatry 1998, 173:54\u201360.","journal-title":"Br J Psychiatry"},{"key":"22_CR14","first-page":"183","volume":"34","author":"MH Rapaport","year":"1998","unstructured":"Rapaport MH, Wolkow RM, Clary CM: Methodologies and outcomes from the sertraline multicenter flexible-dose trials. Psychopharmacol Bull 1998, 34:183\u2013189.","journal-title":"Psychopharmacol Bull"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0447.1997.tb00388.x","volume":"95","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Bakker A, Dunbar G, Judge R: A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 1997, 95:145\u2013152.","journal-title":"Acta Psychiatr Scand"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/ajp.155.1.36","volume":"155","author":"JC Ballenger","year":"1998","unstructured":"Ballenger JC, Wheadon DE, Steiner M, et al.: Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998, 155:36\u201342.","journal-title":"Am J Psychiatry"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1192\/bjp.170.6.549","volume":"170","author":"AG Wade","year":"1997","unstructured":"Wade AG, Lepola U, Koponen HJ, et al.: The effect of citalopram in panic disorder. Br J Psychiatry 1997, 170:549\u2013553.","journal-title":"Br J Psychiatry"},{"key":"22_CR18","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1176\/ajp.155.11.1570","volume":"155","author":"D Michelson","year":"1998","unstructured":"Michelson D, Lydiard RB, Pollack MH, et al.: Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry 1998, 155:1570\u20131577.","journal-title":"Am J Psychiatry"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004714-199310000-00004","volume":"13","author":"R Hoehn-Saric","year":"1993","unstructured":"Hoehn-Saric R, McLeod DR, Hipsley PA: Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993, 13:321\u2013326.","journal-title":"J Clin Psychopharmacol"},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/00004714-199812001-00004","volume":"18","author":"K Rickels","year":"1998","unstructured":"Rickels K, Schweizer E: Panic disorder: long-term pharmacotherapy and discontinuation. J Clin Psychopharmacol 1998, 18(suppl):12S-18S.","journal-title":"J Clin Psychopharmacol"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","volume":"60","author":"G Moroz","year":"1999","unstructured":"Moroz G, Rosenbaum JF: Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. J Clin Psychiatry 1999, 60:604\u2013612.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"22_CR22","first-page":"199","volume":"34","author":"JJ Worthington III","year":"1998","unstructured":"Worthington JJ, III, Pollack MH, Otto MW, McLean RY, Moroz G, Rosenbaum JF. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 1998; 34(2):199\u2013205.","journal-title":"Psychopharmacol Bull"},{"key":"22_CR23","first-page":"224","volume":"24","author":"E Schweizer","year":"1988","unstructured":"Schweizer E, Fox I, Case G, Rickels K: Lorazepam vs. alprazolam in the treatment of panic disorder. Psychopharmacol Bull 1988, 24:224\u2013227.","journal-title":"Psychopharmacol Bull"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004850-199503000-00006","volume":"10","author":"W Boyer","year":"1995","unstructured":"Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995, 10:45\u201349.","journal-title":"Int Clin Psychopharmacol"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-0327(91)90003-B","volume":"21","author":"O Kalus","year":"1991","unstructured":"Kalus O, Asnis GM, Rubinson E, et al.: Desipramine treatment in panic disorder. J Affect Disord 1991, 21:239\u2013244.","journal-title":"J Affect Disord"},{"key":"22_CR26","first-page":"183","volume":"29","author":"RB Lydiard","year":"1993","unstructured":"Lydiard RB, Morton WA, Emmanuel NP, et al.: Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull 1993, 29:183\u2013188.","journal-title":"Psychopharmacol Bull"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00004714-198806000-00010","volume":"8","author":"DJ Munjack","year":"1988","unstructured":"Munjack DJ, Usigli R, Zulueta A, et al.: Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 1988, 8:204\u2013207.","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 8","key":"22_CR28","first-page":"30","volume":"59","author":"JA Boer den","year":"1998","unstructured":"den Boer JA: Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. J Clin Psychiatry 1998, 59(suppl 8):30\u201336.","journal-title":"J Clin Psychiatry"},{"key":"22_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0327(88)90054-7","volume":"14","author":"GB Cassano","year":"1988","unstructured":"Cassano GB, Petracca A, Perugi G, et al.: Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine. J Affect Disord 1988, 14:123\u2013127.","journal-title":"J Affect Disord"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004714-199208000-00007","volume":"12","author":"K Modigh","year":"1992","unstructured":"Modigh K, Westberg P, Eriksson E: Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol 1992, 12:251\u2013261.","journal-title":"J Clin Psychopharmacol"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0924-977X(98)00024-8","volume":"9","author":"Y Sasson","year":"1999","unstructured":"Sasson Y, Iancu I, Fux M, et al.: A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder. Eur Neuropsychopharmacol 1999, 9:191\u2013196.","journal-title":"Eur Neuropsychopharmacol"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-0327(89)90080-3","volume":"16","author":"R Noyes","year":"1989","unstructured":"Noyes R, Jr., Garvey MJ, Cook BL: Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. J Affect Disord 1989, 16:249\u2013257.","journal-title":"J Affect Disord"},{"key":"22_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","volume":"37","author":"DV Sheehan","year":"1980","unstructured":"Sheehan DV, Ballenger J, Jacobsen G: Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980, 37:51\u201359.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR34","doi-asserted-by":"crossref","first-page":"432A","DOI":"10.1097\/00002826-199201001-00226","volume":"15","author":"D Bakish","year":"1992","unstructured":"Bakish D: Reversible monoamine-A inhibitors in panic disorder. Clin Neuropharmacol 1992, 15(suppl):432A-433A.","journal-title":"Clin Neuropharmacol"},{"key":"22_CR35","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/PL00014164","volume":"249","author":"JW Tiller","year":"1999","unstructured":"Tiller JW, Bouwer C, Behnke K: Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group. Eur Arch Psychiatry Clin Neurosci 1999, 249(suppl):S7\u201310.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02244898","volume":"112","author":"IM Vliet van","year":"1993","unstructured":"van Vliet IM, Westenberg HG, den Boer JA: MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study. Psychopharmacology (Berl) 1993, 112:483\u2013489.","journal-title":"Psychopharmacology (Berl)"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10401239909147053","volume":"11","author":"LL Carpenter","year":"1999","unstructured":"Carpenter LL, Leon Z, Yasmin S, Price LH: Clinical experience with mirtazapine in the treatment of panic disorder. Ann Clin Psychiatry 1999, 11:81\u201386.","journal-title":"Ann Clin Psychiatry"},{"key":"22_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4088\/JCP.v60n0108","volume":"60","author":"P Falkai","year":"1999","unstructured":"Falkai P: Mirtazapine: other indications. J Clin Psychiatry 1999, 60(suppl):36\u201340.","journal-title":"J Clin Psychiatry"},{"key":"22_CR39","first-page":"245","volume":"57","author":"NA DeMartinis","year":"1996","unstructured":"DeMartinis NA, Schweizer E, Rickels K: An open-label trial of nefazodone in high comorbidity panic disorder. J Clin Psychiatry 1996, 57:245\u2013248.","journal-title":"J Clin Psychiatry"},{"key":"22_CR40","first-page":"667","volume":"32","author":"MH Pollack","year":"1996","unstructured":"Pollack MH, Worthington JJ, III, Otto MW, et al.: Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull 1996, 32:667\u2013670.","journal-title":"Psychopharmacol Bull"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00004850-199911000-00002","volume":"14","author":"E Leinonen","year":"1999","unstructured":"Leinonen E, Skarstein J, Behnke K, et al.: Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Int Clin Psychopharmacol 1999, 14:329\u2013337.","journal-title":"Int Clin Psychopharmacol"},{"key":"22_CR42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004714-198302000-00006","volume":"3","author":"DV Sheehan","year":"1983","unstructured":"Sheehan DV, Davidson J, Manschreck T, Van Wyck FJ: Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983, 3:28\u201331.","journal-title":"J Clin Psychopharmacol"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02805991","volume":"127","author":"IM Vliet van","year":"1996","unstructured":"van Vliet IM, Westenberg HG, den Boer JA: Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder. Psychopharmacology (Berl) 1996, 127:174\u2013180.","journal-title":"Psychopharmacology (Berl)"},{"key":"22_CR44","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1176\/ajp.146.7.914","volume":"146","author":"DR Gastfriend","year":"1989","unstructured":"Gastfriend DR, Rosenbaum JF: Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. Am J Psychiatry 1989, 146:914\u2013916.","journal-title":"Am J Psychiatry"},{"key":"22_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1749-6632.1994.tb44075.x","volume":"713","author":"J Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D: The cholecystokinin hypothesis of anxiety and panic disorder. Ann N Y Acad Sci 1994, 713:273\u2013282.","journal-title":"Ann N Y Acad Sci"},{"key":"22_CR46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0006-3223(94)00190-E","volume":"37","author":"MS Kramer","year":"1995","unstructured":"Kramer MS, Cutler NR, Ballenger JC, et al.: A placebocontrolled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry 1995, 37:462\u2013466.","journal-title":"Biol Psychiatry"},{"key":"22_CR47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0006-3223(99)00090-6","volume":"46","author":"AC Pande","year":"1999","unstructured":"Pande AC, Greiner M, Adams JB, et al.: Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder. Biol Psychiatry 1999, 46:860\u2013862.","journal-title":"Biol Psychiatry"},{"key":"22_CR48","first-page":"134","volume":"55","author":"CL Woodman","year":"1994","unstructured":"Woodman CL, Noyes RJr: Panic disorder: treatment with valproate. J Clin Psychiatry 1994, 55:134\u2013136.","journal-title":"J Clin Psychiatry"},{"key":"22_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-3223(93)90010-B","volume":"33","author":"PE Keck","year":"1993","unstructured":"Keck PE, Jr., Taylor VE, Tugrul KC, et al.: Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 1993, 33:542\u2013546.","journal-title":"Biol Psychiatry"},{"key":"22_CR50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1176\/appi.ajp.157.4.659-a","volume":"157","author":"M Etxebeste","year":"2000","unstructured":"Etxebeste M, Aragues E, Malo P, Pacheco L: Olanzapine and panic attacks [letter]. Am J Psychiatry 2000, 157:659\u2013660.","journal-title":"Am J Psychiatry"},{"key":"22_CR51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpsyc.1996.01830080079013","volume":"53","author":"DH Barlow","year":"1996","unstructured":"Barlow DH, Lehman CL: Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. Arch Gen Psychiatry 1996, 53:727\u2013735.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0005-7967(93)90026-Q","volume":"31","author":"MJ Telch","year":"1993","unstructured":"Telch MJ, Lucas JA, Schmidt NB, et al.: Group cognitivebehavioral treatment of panic disorder. Behav Res Ther 1993, 31:279\u2013287.","journal-title":"Behav Res Ther"},{"key":"22_CR53","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0033-3182(99)71207-7","volume":"40","author":"JM Dyckman","year":"1999","unstructured":"Dyckman JM, Rosenbaum RL, Hartmeyer RJ, Walter LJ: Effects of psychological intervention on panic attack patients in the emergency department. Psychosomatics 1999, 40:422\u2013427.","journal-title":"Psychosomatics"},{"key":"22_CR54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1037\/0022-006X.66.2.231","volume":"66","author":"WA Wade","year":"1998","unstructured":"Wade WA, Treat TA, Stuart GL: Transporting an empirically supported treatment for panic disorder to a service clinic setting: a benchmarking strategy. J Consult Clin Psychol 1998, 66:231\u2013239.","journal-title":"J Consult Clin Psychol"},{"key":"22_CR55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1037\/0022-006X.68.3.506","volume":"68","author":"GL Stuart","year":"2000","unstructured":"Stuart GL, Treat TA, Wade WA: Effectiveness of an empirically based treatment for panic disorder delivered in a service clinic setting: 1-year follow-up. J Consult Clin Psychol 2000, 68:506\u2013512. A good review.","journal-title":"J Consult Clin Psychol"},{"key":"22_CR56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1037\/0022-006X.65.1.178","volume":"65","author":"MG Newman","year":"1997","unstructured":"Newman MG, Kenardy J, Herman S, Taylor CB: Comparison of palmtop-computer-assisted brief cognitive-behavioral treatment to cognitive-behavioral treatment for panic disorder. J Consult Clin Psychol 1997, 65:178\u2013183.","journal-title":"J Consult Clin Psychol"},{"key":"22_CR57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","volume":"50","author":"DW Black","year":"1993","unstructured":"Black DW, Wesner R, Bowers W, Gabel J: A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993, 50:44\u201350.","journal-title":"Arch Gen Psychiatry"},{"key":"22_CR58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1037\/0022-006X.67.4.583","volume":"67","author":"DM Clark","year":"1999","unstructured":"Clark DM, Salkovskis PM, Hackmann A, et al.: Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 1999, 67:583\u2013589.","journal-title":"J Consult Clin Psychol"},{"key":"22_CR59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.151.6.876","volume":"151","author":"DA Spiegel","year":"1994","unstructured":"Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A: Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry 1994, 151:876\u2013881.","journal-title":"Am J Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-001-0022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-001-0022-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-001-0022-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:40:57Z","timestamp":1559421657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-001-0022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11920-001-0022-1","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}